Paragonix Technologies offers solutions for organ transplantation, providing support for members of the transplant community.

Paragonix

Paragonix Technologies is a rapidly growing medical device manufacturer that designs, manufactures, and sells organ transplant transport devices. Our dynamic team is committed to improving the lives of transplant patients by providing advanced technologies to ensure optimal preservation for donor organs on the journey to their ultimate recipients. Our primary offices are located in Waltham, MA.

Paragonix Technologies, Inc.

Are you looking to join the team at Paragonix? Explore new opportunities on our career page today! 

We're on the lookout for a Sales Operations Specialist to contribute to our daily operations. The ideal candidate will be a proactive self-starter and a collaborative team player with strong communication skills. This dynamic role involves working closely with leadership to maintain accurate data records and streamline daily processes. 

Apply now and discover more about this exciting opportunity: https://lnkd.in/g9gpUcmu

#hiring #jobopportunity #salesops

📢 We're accepting abstracts for #ISHLT2025! 📖 💡  We want your science in the treatment of advanced #heart and #lung disease, transplantation, and #MCS. Visit 🔗 https://bit.ly/3WNkEqX to learn more and get started.

Pushing the historical limits to break new barriers!

Dr. Fiedler is always a fantastic speaker - really loved getting to hear her unique perspective when she joined as a guest on the Paragonix podcast. Well worth a watch! https://lnkd.in/eAxWw-XB
#everypossibleangle

Study of more than 1200 heart-transplant recipients from the GUARDIAN-Heart Registry finds that a simple, static cold storage preservation system significantly extends safe out-of-body time for heart allografts.

🔗: https://lnkd.in/giCjP7wu

David D'Alessandro, Jacob Schroder, Dan Meyer, Scott Silvestry, MARZIA LEACCHE, Si Pham, Hannah Copeland, Kawabori Masashi, Koji Takeda, Andreas Zuckermann

The Texas Transplantation Society, Inc.'s annual scientific meeting was one of the best ways to wrap up the month. It was an honor to share our latest innovations at a conference dedicated to cutting-edge advancements across the landscape of transplantation.

Thank you for representing the Paragonix team, Amy!

Interested in learning the latest from the Journal of Heart and Lung Transplantation? 

Check out the last episode of the JHLT Podcast, featuring lead GUARDIAN-Heart investigator, Dr. David D'Alessandro, first author on the GUARDIAN study featuring 1-year clinical outcomes of advanced hypothermic preservation with the SherpaPak CTS. 

"We looked at the difference in curves of risk of severe PGD as a function of ischemic time," Dr. D'Alessandro shared. "At all time points, ice is at higher risk of PGD than this system. Now, at lower ischemic times of two hours, the risk of severe PGD with ice is pretty low...but it's even lower with this device."

Learn more about the GUARDIAN manuscript, or listen to the interview at: https://lnkd.in/g6kt82ft

Metric
Company Name	Paragonix
Symbol
MSH ID	COM:PARAGONIXTECHNOLOGIES
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Technology
Country	US
Stage
Employee Count	114
Website	paragonixtechnologies.com
LinkedIn	paragonix
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PARAGONIXTECHNOLOGIES

Paragonix

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue